HIV
The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)
This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.
Pros and Cons of Lencapavir as PrEP: Gordon Crofoot, MD, PA
Long-Acting Injectable Lenacapavir Works in Both Prevention, Treatment of HIV: Gordon Crofoot, MD, PA
Caregiver Dependence Is Key to HIV Care in Children: Priscilla Tsondai, MD, MPH
Living With HIV, Leading Through Experience: Bridgette J. Picou, LVN, ACLPN
CROI 2025 Insights: Evolving HIV Treatment Landscape and Practice-Changing Developments
CD4 T-cell and Lymphocyte Monitoring: Clinical Significance in HIV Treatment
Long-Acting HIV Therapies: Real-World Data and Clinical Application
HIV Therapy Without Integrase Inhibitor: Practical Advantages and Targeted Patient Populations
Phase 3 HIV Treatment Switch Studies: Key Findings From Recent Clinical Trials
Changing Patient Demographics in HIV and Impacts of Polypharmacy on Treatment
Elevating Equitable Health Care for the LGBTQ+ Community
Community Outreach Is Enabling CeSHHAR to Close HIV Care Gaps in Zimbabwe
Podcast: This Week in Managed Care—COVID-19 Racial Disparities and Other Health News
Podcast: This Week in Managed Care—Medicare Executive Order and Other Health News
Podcast: This Week in Managed Care—HIV Screening Rates and Other Health News
Podcast: This Week in Managed Care—Opioid Ruling and Settlement, and Other Health News
Podcast: This Week in Managed Care—Limiting Surprising Medical Bills and Other Health News
Podcast: This Week in Managed Care—USPSTF Recommends PrEP for HIV and Other Health News
Podcast: This Week in Managed Care—Cardiovascular Prevention Guidelines and Other Health News
Podcast: This Week in Managed Care—FDA's Gottlieb Resigns and Other Health News
